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Background
The vesicular monoamine transporter pumps dopamine,
norepinephrine, and five-hydroxy tryptamine into synap-
tic storage vesicles. A variety of exogenous amines are also
substrates for this transporter. Once stored, amines can be
redistributed out of vesicles by compounds that inhibit
the VMAT or by substrates for the VMAT. Recently, data
were reported comparing uptake of dopamine and
tyramine into vesicles and comparing ability of
dopamine, tyramine, and a variety of amphetamine ana-
logues to redistribute stored dopamine and tyramine out
of vesicles [1]. The kinetics of dopamine and tyramine
uptake are markedly different, and the maximum amount
of stored amine that is redistributed out of vesicles differs
substantially when comparing various displacers. A
potential explanation is the presence of a storage compart-
ment within each vesicle for which various amines have
differing affinities.
Objective
The objective of this project is to explain why the maxi-
mum velocity of uptake varies between different amines
and to provide a quantitative/kinetic description of the
storage compartment within a vesicle.
Method
We developed a computational model for simulating
dopamine and tyramine uptake into vesicles and their dis-
placement by various types of compounds. The model
parameters include transporter mediated uptake into ves-
icles, diffusion in and out of vesicles, on-rate for binding
to a storage compartment, off-rate for unbinding from a
storage compartment, and capacity of the storage com-
partment.
Results
Regarding uptake studies, the membrane diffusion rate
constant controls the time to reach steady-state conditions
and the magnitude of uptake. More diffusible compounds
reach lower steady-state values than do less permeable
compounds. The time to reach steady-state is also quicker
for more permeable compounds. Therefore, the apparent
maximum velocity, as measured by uptake studies, is
lesser for the more permeable compounds. Regarding an
intra-vesicular storage compartment, a satisfactory model
uses a storage compartment with a capacity of 500 bind-
ing sites and a very fast on-rate which is held constant for
all amines. Dopamine is tightly bound to this compart-
ment because of a slow off-rate. Tyramine is loosely
bound because of a fast off-rate. Amphetamine and ana-
logues have intermediate off-rates. This model results in a
maximum vesicular amine displacement of 100% when
dopamine is displacing either dopamine or tyramine, of
86% when tyramine is displacing dopamine, of 60%
when an inhibitor of the VMAT is displacing tyramine,
and of 47% when an inhibitor of the VMAT is displacing
dopamine.
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